University Hospital of Zurich-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

    Eye (Basingstoke)

  2. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

2022

  1. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

2021

  1. Three-year outcomes of neovascular age-related macular degeneration in eyes that do not develop macular atrophy or subretinal fibrosis

    Translational Vision Science and Technology, Vol. 10, Núm. 13